TISLELIZUMAB

Clinical trials for TISLELIZUMAB explained in plain language.

Never miss a new study

Get alerted when new TISLELIZUMAB trials appear

Sign up with your email to follow new studies for TISLELIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

New combo therapy shows promise for tough liver cancer cases

Disease control Completed

This study tested a new treatment for people with advanced liver cancer that has spread into the major blood vessels of the liver. The treatment combines a special type of radiation (moderate-dose hypofractionated radiotherapy) with an immunotherapy drug called tislelizumab. The …

Matched conditions: TISLELIZUMAB

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 17, 2026 00:28 UTC

TISLELIZUMAB

Get alerted when new TISLELIZUMAB trials appear

New combo therapy shows promise for tough liver cancer cases